Thomas C Robertson1,2, Kathryn Hall3, Susan Bear4, Kyle J Thompson5, Timothy Kuwada3, Keith S Gersin3. 1. Division of Bariatric Surgery, Carolinas Medical Center, 2630 E 7th St, Charlotte, NC, 28204, USA. Calloway4@gmail.com. 2. OhioHealth Physician Group, Riverside Methodist Hospital, Columbus, OH, USA. Calloway4@gmail.com. 3. Division of Bariatric Surgery, Carolinas Medical Center, 2630 E 7th St, Charlotte, NC, 28204, USA. 4. Clinical Pharmacy Services, Carolinas Medical Center, Charlotte, NC, USA. 5. Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
Abstract
INTRODUCTION: The use of non-narcotic modalities for postoperative analgesia may decrease exposure to opioids, thereby limiting their deleterious effects. The objective of this study was to determine the effectiveness of a liposomal bupivacaine transverse abdominis plane (TAP) block prior to laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric bypass (LRYGB). The primary outcome was total postoperative morphine equivalents. METHODS: A single-surgeon, IRB-approved retrospective chart review was performed on consecutive patients who underwent LRYGB or LSG from 2010 to 2016. Patients were grouped according to those who received TAP blocks immediately preoperatively with rescue opioids (TAP group) and those who received PCA only (PCA group). Total parenteral morphine equivalents (PME) were calculated. Numerical pain scores were collected immediately following surgery, 12 h postoperatively, and on the day of discharge. Median length of stay (LOS) and 30-day readmissions were also calculated. RESULTS: There were 440 patients who met inclusion criteria. The TAP group had significantly less opioid use (total PME) than the PCA, irrespective of surgical approach (70.4 ± 2.7 PCA LRYGB and 26.5 ± 1.5 TAP block LRYGB, p value ≤ 0.0001; 60.0 ± 3.5 PCA LSG vs. and 24.1 ± 2.0 TAP block LSG, p value < 0.0001). Median LOS was 2.0 days for both PCA groups, whereas LOS decreased to 1.0 day for both groups of patients receiving TAP blocks (p < 0.0001). Pain scores immediately following and 12 h after surgery were significantly elevated in the TAP LRYGB versus PCA LRYGB (p < 0.05) and immediately following surgery for PCA versus TAP block for LSG (p = 0.0109). CONCLUSIONS: TAP blocks with liposomal bupivacaine lead to significantly less use of parenteral morphine equivalents and decreased LOS compared to PCA alone. Pain scores were higher in the TAP LRYGB group compared to the LRYGB PCA group, with no differences in pain scores noted in the LSG groups.
INTRODUCTION: The use of non-narcotic modalities for postoperative analgesia may decrease exposure to opioids, thereby limiting their deleterious effects. The objective of this study was to determine the effectiveness of a liposomal bupivacaine transverse abdominis plane (TAP) block prior to laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric bypass (LRYGB). The primary outcome was total postoperative morphine equivalents. METHODS: A single-surgeon, IRB-approved retrospective chart review was performed on consecutive patients who underwent LRYGB or LSG from 2010 to 2016. Patients were grouped according to those who received TAP blocks immediately preoperatively with rescue opioids (TAP group) and those who received PCA only (PCA group). Total parenteral morphine equivalents (PME) were calculated. Numerical pain scores were collected immediately following surgery, 12 h postoperatively, and on the day of discharge. Median length of stay (LOS) and 30-day readmissions were also calculated. RESULTS: There were 440 patients who met inclusion criteria. The TAP group had significantly less opioid use (total PME) than the PCA, irrespective of surgical approach (70.4 ± 2.7 PCA LRYGB and 26.5 ± 1.5 TAP block LRYGB, p value ≤ 0.0001; 60.0 ± 3.5 PCA LSG vs. and 24.1 ± 2.0 TAP block LSG, p value < 0.0001). Median LOS was 2.0 days for both PCA groups, whereas LOS decreased to 1.0 day for both groups of patients receiving TAP blocks (p < 0.0001). Pain scores immediately following and 12 h after surgery were significantly elevated in the TAP LRYGB versus PCA LRYGB (p < 0.05) and immediately following surgery for PCA versus TAP block for LSG (p = 0.0109). CONCLUSIONS:TAP blocks with liposomal bupivacaine lead to significantly less use of parenteral morphine equivalents and decreased LOS compared to PCA alone. Pain scores were higher in the TAP LRYGB group compared to the LRYGB PCA group, with no differences in pain scores noted in the LSG groups.
Entities:
Keywords:
Bariatric surgery; Liposomal bupivacaine; TAP block
Authors: Eric Albrecht; Kyle R Kirkham; Ryan V W Endersby; Vincent W S Chan; Timothy Jackson; Allan Okrainec; Todd Penner; Rongyu Jin; Richard Brull Journal: Obes Surg Date: 2013-08 Impact factor: 4.129
Authors: Jonathan Lissauer; Kenneth Mancuso; Christopher Merritt; Amit Prabhakar; Alan David Kaye; Richard D Urman Journal: Best Pract Res Clin Anaesthesiol Date: 2014-05-09
Authors: Jacob Hutchins; Rachel Isaksson Vogel; Rahel Ghebre; Amy McNally; Levi S Downs; Elizabeth Gryzmala; Melissa A Geller Journal: Int J Gynecol Cancer Date: 2015-06 Impact factor: 3.437
Authors: Lucia Gagliese; Lynn R Gauthier; Alison K Macpherson; Melissa Jovellanos; Vincent W S Chan Journal: Pain Med Date: 2008-04 Impact factor: 3.750
Authors: A A El-Dawlatly; A Turkistani; S C Kettner; A-M Machata; M B Delvi; A Thallaj; S Kapral; P Marhofer Journal: Br J Anaesth Date: 2009-04-17 Impact factor: 9.166